Loading...
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
The optimal sequence of systemic chemotherapy in metastatic breast cancer (MBC) is unknown. We report the case of a woman who was successfully treated with nanoparticle albumin-bound (nab)-paclitaxel for triple negative MBC in our institution. In November 2008, a 48-year-old woman underwent surgical...
Saved in:
Published in: | Anticancer Drugs |
---|---|
Main Authors: | , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Lippincott Williams & Wilkins
2015
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243802/ https://ncbi.nlm.nih.gov/pubmed/25115342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000159 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|